Oral anticoagulation in patients with atrial fibrillation and end-stage kidney disease
Atrial fibrillation is highly prevalent in patients with end -stage kidney disease. For patients with atrial fibrillation but normal kidney function, the net clinical benefit of oral anticoagulation with vitamin K antagonists and non -vitamin K oral anticoagulants in preventing stroke against the he...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Publicações Ciência e Vida,
2022-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |